Status:
RECRUITING
Atrial Late Gadolinium Enhancement in Patients with Repaired Congenital Heart Disease
Lead Sponsor:
Boston Children's Hospital
Conditions:
Congenital Heart Disease
Fibrosis Myocardial
Eligibility:
All Genders
13+ years
Brief Summary
In this research study the investigators want to learn more about how well the investigators can visualize scar tissue in the heart by MRI. In patients with congenital heart disease who need a procedu...
Detailed Description
Atrial arrhythmias including intra-atrial reentrant tachycardia (IART) and atrial fibrillation (AF) routinely develop after surgical repair of congenital heart disease (CHD), contributing to heart fai...
Eligibility Criteria
Inclusion
- Patients \>13 years old with congenital heart disease referred for cardiac MRI and receiving gadolinium as part of routine clinical care or for pre-ablation planning will be included.
Exclusion
- Those with self-reported anxiety or claustrophobia and/or the presence of a permanent pacemaker or implantable cardioverter defibrillator will be excluded.
Key Trial Info
Start Date :
March 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2029
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05241418
Start Date
March 23 2022
End Date
June 30 2029
Last Update
February 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02130